The aOECs Facilitate the Neuronal Differentiation of Neural Stem Cells in the Inflammatory Microenvironment Through Up-Regulation of Bioactive Factors and Activation of Wnt3/β-Catenin Pathway

被引:6
|
作者
He, Yuqing [1 ,6 ]
Jiang, Yizhen [2 ]
Dong, Lianwei [3 ,4 ]
Jiang, Chao [5 ]
Zhang, Lingling [6 ]
Zhang, Gaorong [6 ]
Yang, Hao [1 ,6 ]
Liu, Juan [1 ]
机构
[1] Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Ningxia, Peoples R China
[2] Shaanxi Univ Tradit Chinese Med, Basic Med Sch Acad, Xianyang 712046, Peoples R China
[3] Ningxia Hui Autonomous Reg Hosp, Yinchuan 750021, Ningxia, Peoples R China
[4] Res Inst Tradit Chinese Med, Yinchuan 750021, Ningxia, Peoples R China
[5] Xi An Jiao Tong Univ, Hong Hui Hosp, Dept Spine Surg, Xian 710054, Peoples R China
[6] Xi An Jiao Tong Univ, Hong Hui Hosp, Translat Med Ctr, Xian 710054, Peoples R China
基金
中国国家自然科学基金;
关键词
Activated olfactory ensheathing cells; Neural stem cells; Neuronal differentiation; Neuroinflammation; Cell therapy; Spinal cord injury; OLFACTORY ENSHEATHING CELLS; SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; TRANSPLANTATION; CURCUMIN; PATHOLOGY;
D O I
10.1007/s12035-022-03113-w
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The therapeutic application of neural stem cells (NSCs) in the central nerve system (CNS) injury is a promising strategy for combating irreversible neuronal loss. However, a variety of obvious inflammatory responses following nerve injury rapidly create an unfavorable microenvironment for survival and neuronal differentiation of NSCs in lesion area, limiting the efficacy of NSC-based therapy for CNS injury. It remained unknown how to effectively increase the neuronal differentiation efficiency of NSCs through transplantation. Here, we demonstrated that curcumin (CCM)-activated olfactory ensheathing cells (aOECs) effectively promoted neuronal differentiation of NSCs in the activated microglial inflammatory condition, and co-transplantation of aOECs and NSCs improved neurological recovery of rats after spinal cord injury (SCI), as evidenced by higher expression levels of neuronal markers and lower expression levels of glial markers in the differentiated cells, greater number of Tuj-1-positive cells as well as higher Basso, Beattie, and Bresnahan (BBB) locomotor scale, compared to the corresponding controls. Pathologically, hematoxylin and eosin (HE) staining and immunostaining also showed that aOECs remarkably enhanced the in vivo neuronal differentiation of NSCs and migration, and nerve repair. Further analysis revealed that the underlying mechanisms of aOECs potentiating the neuronal conversion of NSCs under inflammatory environment were tightly associated with up-regulation of anti-inflammatory cytokines and neurotrophic factors in OECs, and importantly, the activation of Wnt3/beta-catenin pathway was likely involved in the mechanisms underlying the observed cellular events. Therefore, this study provides a promising strategy for SCI repair by co-transplantation of aOECs and NSCs.
引用
收藏
页码:789 / 806
页数:18
相关论文
共 50 条
  • [21] WNT/β-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells
    Hao, J
    Li, TG
    Qi, XX
    Zhao, DF
    Zhao, GQ
    DEVELOPMENTAL BIOLOGY, 2006, 290 (01) : 81 - 91
  • [22] Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment
    Oo, Aung Ko Ko
    Calle, Anna Sanchez
    Nair, Neha
    Mahmud, Hafizah
    Vaidyanath, Arun
    Yamauchi, Junya
    Khayrani, Aprilliana Cahya
    Du, Juan
    Alam, Md Jahangir
    Seno, Akimasa
    Mizutani, Akifumi
    Murakami, Hiroshi
    Iwasaki, Yoshiaki
    Chen, Ling
    Kasai, Tomonari
    Seno, Masaharu
    TRANSLATIONAL ONCOLOGY, 2018, 11 (03): : 653 - 663
  • [23] Stanniocalcin 2 Promotes Neuronal Differentiation in Neural Stem/Progenitor Cells of the Mouse Subventricular Zone Through Activation of AKT Pathway
    Guo, Zhenyu
    Zhang, Hanyue
    Jingele, Xinbate
    Yan, Jing
    Wang, Xinxiang
    Liu, Yingxi
    Huang, Tingqin
    Liu, Chongxiao
    STEM CELLS AND DEVELOPMENT, 2024, 33 (19-20) : 551 - 561
  • [24] ET-1 Promotes Differentiation of Periodontal Ligament Stem Cells into Osteoblasts through ETR, MAPK, and Wnt/β-Catenin Signaling Pathways under Inflammatory Microenvironment
    Liang, Li
    Zhou, Wei
    Yang, Nan
    Yu, Jifeng
    Liu, Hongchen
    MEDIATORS OF INFLAMMATION, 2016, 2016
  • [25] Molecular mechanism of AQP3 in regulating differentiation and apoptosis of lung cancer stem cells through Wnt/GSK-3β/β-Catenin pathway
    Liu, Chunshui
    Liu, Lingyun
    Zhang, Ye
    Jing, Hongyu
    JOURNAL OF BUON, 2020, 25 (04): : 1714 - 1720
  • [26] 20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3β in the Wnt/ GSK-3β/β-catenin pathway
    Lin, Kaili
    Liu, Bin
    Lim, Sze-Lam
    Fu, Xiuqiong
    Sze, Stephen C-W
    Yung, Ken K-L
    Zhang, Shiqing
    JOURNAL OF GINSENG RESEARCH, 2020, 44 (03) : 475 - 482
  • [27] NEUROTROPHIN-3 MAY CONTRIBUTE TO NEURONAL DIFFERENTIATION OF MESENCHYMAL STEM CELLS THROUGH THE ACTIVATION OF THE BONE MORPHOGENETIC PROTEIN PATHWAY
    Li, Lei
    Li, Yunpeng
    Jiang, Hongkun
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2015, 20 (03) : 385 - 403
  • [28] Semaglutide promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells through activation of the Wnt/LRP5/β-catenin signaling pathway
    Tian, Yawei
    Liu, Huiming
    Bao, Xiaoxue
    Li, Yukun
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [29] Molecular mechanism of aquapontin (AQP3) in regulating differentiation and apoptosis of lung cancer stem cells through Wnt/GSK-3β/β-Catenin pathway
    Liu, Chunshui
    Liu, Lingyun
    Zhang, Ye
    Jing, Hongyu
    JOURNAL OF BUON, 2020, 25 (02): : 828 - 834
  • [30] Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway
    Zhao, Jinlong
    Liang, Guihong
    Yang, Junzheng
    Huang, Hetao
    Dou, Yaoxing
    Gu, Zhuoxu
    Liu, Jun
    Zeng, Lingfeng
    Yang, Weiyi
    PHARMACEUTICALS, 2024, 17 (01)